98%
921
2 minutes
20
Hydrogen peroxide (HO) is a key signaling molecule in tumor progression, making its real-time detection vital for elucidating the complex mechanisms underlying tumorigenesis. Herein, we report a rationally colorimetric sensing platform for rapid tumor screening, leveraging the bifunctional enzyme-like activity of a heterostructured h-NiO/CoO/C nanosphere. Notably, by activating electron structure reconstruction with abundant oxygen vacancies and utilizing a dual-non-precious-metal method, h-NiO/CoO/C nanosphere enhances catalytic performance beyond the limitations of single-non-precious-metal-doped nanomaterials (e.g., NiO/C and CoO/C), remarkably boosting peroxidase (POD)-mimicking catalytic activities. Intriguingly, h-NiO/CoO/C shows a substantial enhancement in POD capability in comparison with single NiO/C and CoO/C, indicating superior sensitivity for monitoring endogenous HO. By integrating h-NiO/CoO/C with the chromogenic reaction principle, a highly rapid and sensitive endogenous HO sensor is constructed. Furthermore, the resulting color change is analyzed via a smartphone application to provide instant, semiquantitative data. The smartphone-based colorimetric detection of HO is realized via mutual verification by these two strategies. The assay data suggested that the POD-mimicking catalytic activity determination range is 0.01-2.8 mM, with a low limit of detection of 7.5 μM. This study demonstrates the rational design of highly efficient POD-mimicking nanozymes by engineering their structure-performance relationship, paving a new avenue for developing advanced nanozymes and providing a rapid, accessible toolkit for tumor screening.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.talanta.2025.128777 | DOI Listing |
J Appl Clin Med Phys
September 2025
Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia, USA.
Purpose: Real‑time magnetic resonance-guided radiation therapy (MRgRT) integrates MRI with a linear accelerator (Linac) for gating and adaptive radiotherapy, which requires robust image‑quality assurance over a large field of view (FOV). Specialized phantoms capable of accommodating this extensive FOV are therefore essential. This study compares the performance of four commercial MRI phantoms on a 0.
View Article and Find Full Text PDFJ Appl Clin Med Phys
September 2025
Department of Radiation Oncology, University of Utah, Salt Lake City, Utah, USA.
Purpose: The development of on-board cone-beam computed tomography (CBCT) has led to improved target localization and evaluation of patient anatomical change throughout the course of radiation therapy. HyperSight, a newly developed on-board CBCT platform by Varian, has been shown to improve image quality and HU fidelity relative to conventional CBCT. The purpose of this study is to benchmark the dose calculation accuracy of Varian's HyperSight cone-beam computed tomography (CBCT) on the Halcyon platform relative to fan-beam CT-based dose calculations and to perform end-to-end testing of HyperSight CBCT-only based treatment planning.
View Article and Find Full Text PDFBMC Endocr Disord
September 2025
Internal Medicine Department, Faculty of Medicine, Beni-Suef University, Beni-Suef City, 62514, Egypt.
Background: Thyroid nodules (TNs) are frequent and often benign. Accurately differentiating between benign and malignant nodules is crucial for proper management. This research aims to use ultrasonography to examine TNs and identify possible risk factors in order to improve patient outcomes and diagnostic accuracy.
View Article and Find Full Text PDFInt J Colorectal Dis
September 2025
Internal Medicine Department, Mirwais Regional Hospital, Kandahar, Afghanistan.
Background: The primary treatment for colorectal cancer, which is very prevalent, is surgery. Anastomotic leaking poses a significant risk following surgery. Intestinal perfusion can be objectively and instantly assessed with indocyanine green fluorescence imaging, which may lower leakage rates and enhance surgical results.
View Article and Find Full Text PDFNat Aging
September 2025
Aging Biomarker Consortium (ABC), Beijing, China.
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age-related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual's physiological and molecular state, across diverse Chinese cohorts.
View Article and Find Full Text PDF